Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices 10367 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–03871 Filed 2–23–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Center 

for Preparedness and Response, (BSC, 

CPR); Meeting 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Board of Scientific Counselors, 

Center for Preparedness and Response, 

(BSC, CPR). This is a virtual meeting 

that is open to the public, limited only 

by the number of internet conference 

accesses available, which is 500. Time 

will be available for public comment. 

Pre-registration is required by accessing 

the link in the addresses section. 

DATES: The meeting will be held on 

March 24, 2022, from 1:00 p.m. to 3:00 

p.m., EDT. 

ADDRESSES: Zoom Virtual Meeting. If 

you wish to attend the virtual meeting, 

please pre-register by accessing the link 

at: https://cdc.zoomgov.com/webinar/ 

register/WN_M20Tm8MUTbihUhvg0BcSg. Instructions to access the 

Zoom virtual meeting will be provided 

in the link following registration. 

FOR FURTHER INFORMATION CONTACT: 

Dometa Ouisley, Office of Science and 

Public Health Practice, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, Mailstop–H21–6, 

Atlanta, Georgia 30329–4027, 

Telephone: (404) 639–7450; Facsimile: 

(678) 669–1667; Email: DOuisley@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Board is charged with 

providing advice and guidance to the 

Secretary, Department of Health and 

Human Services (HHS), the Assistant 

Secretary for Health (ASH), the Director, 

Centers for Disease Control and 

Prevention (CDC), and the Director, 

Center for Preparedness and Response 

(CPR), concerning strategies and goals 

for the programs and research within 

CPR, monitoring the overall strategic 

direction and focus of the CPR Divisions 

and Offices, and administration and 

oversight of peer review for CPR 

scientific programs. For additional 

information about the Board, please 

visit: https://www.cdc.gov/cpr/bsc/ 

index.htm. 

Matters To Be Considered: The agenda 

will include: (1) BSC CPR Polio 

Containment Workgroup (PCWG) 

Update; and (2) Strategic Capacity 

Building and Innovation Program 

Review Working Group Update. Agenda 

items are subject to change as priorities 

dictate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–03869 Filed 2–23–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel; 

(SEP)—RFA–TS–22–001: Identify and 

Evaluate Potential Risk Factors for 

Amyotrophic Lateral Sclerosis (ALS). 

Date: June 17, 2022 

Time: 8:30 a.m.–5:30 p.m., EDT. 

Place: Videoconference. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Mikel Walters, Ph.D., Scientific Review 

Officer, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone 

(404)639–0913, MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–03870 Filed 2–23–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10398 #57] 

Medicaid and Children’s Health 

Insurance Program (CHIP) Generic 

Information Collection Activities: 

Proposed Collection; Comment 

Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: On May 28, 2010, the Office 

of Management and Budget (OMB) 

issued Paperwork Reduction Act (PRA) 

guidance related to the ‘‘generic’’ 

clearance process. Generally, this is an 

expedited process by which agencies 

may obtain OMB’s approval of 


jspears on DSK121TN23PROD with NOTICES1